382 related articles for article (PubMed ID: 23100742)
1. Bioactive compounds from marine actinomycetes.
Solanki R; Khanna M; Lal R
Indian J Microbiol; 2008 Dec; 48(4):410-31. PubMed ID: 23100742
[TBL] [Abstract][Full Text] [Related]
2. Marine actinobacteria: an important source of bioactive natural products.
Manivasagan P; Kang KH; Sivakumar K; Li-Chan EC; Oh HM; Kim SK
Environ Toxicol Pharmacol; 2014 Jul; 38(1):172-88. PubMed ID: 24959957
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutically active secondary metabolites of marine actinobacteria.
Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
[TBL] [Abstract][Full Text] [Related]
4. Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products.
Subramani R; Sipkema D
Mar Drugs; 2019 Apr; 17(5):. PubMed ID: 31035452
[TBL] [Abstract][Full Text] [Related]
5. Marine Actinomycetes Associated with Stony Corals: A Potential Hotspot for Specialized Metabolites.
Siro G; Pipite A; Christi K; Srinivasan S; Subramani R
Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889068
[TBL] [Abstract][Full Text] [Related]
6. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
Subramani R; Aalbersberg W
Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Investigation of Potential Novel Marine Psychrotolerant Actinomycetes sp. Isolated from the Bay-of-Bengal.
Ghosh M; Gera M; Singh J; Prasad R; Pulicherla KK
Curr Genomics; 2020 May; 21(4):271-282. PubMed ID: 33071620
[TBL] [Abstract][Full Text] [Related]
8. Diversity and Biotechnological Potential of Marine Actinomycetes from India.
Sarkar G; Suthindhiran K
Indian J Microbiol; 2022 Dec; 62(4):475-493. PubMed ID: 35601673
[TBL] [Abstract][Full Text] [Related]
9. Secondary metabolites and biodiversity of actinomycetes.
Selim MSM; Abdelhamid SA; Mohamed SS
J Genet Eng Biotechnol; 2021 May; 19(1):72. PubMed ID: 33982192
[TBL] [Abstract][Full Text] [Related]
10. Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.
Tarasova EV; Luchnikova NA; Grishko VV; Ivshina IB
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375819
[TBL] [Abstract][Full Text] [Related]
11. The Madeira Archipelago As a Significant Source of Marine-Derived Actinomycete Diversity with Anticancer and Antimicrobial Potential.
Prieto-Davó A; Dias T; Gomes SE; Rodrigues S; Parera-Valadez Y; Borralho PM; Pereira F; Rodrigues CM; Santos-Sanches I; Gaudêncio SP
Front Microbiol; 2016; 7():1594. PubMed ID: 27774089
[TBL] [Abstract][Full Text] [Related]
12. Bioprospection and secondary metabolites profiling of marine
Chakraborty B; Kumar RS; Almansour AI; Gunasekaran P; Nayaka S
Saudi J Biol Sci; 2022 Feb; 29(2):667-679. PubMed ID: 35197732
[TBL] [Abstract][Full Text] [Related]
13. Terrestrial actinomycetes from diverse locations of Uttarakhnad, India: Isolation and screening for their antibacterial activity.
Kumar V; Bisht GS; Gusain O
Iran J Microbiol; 2013 Sep; 5(3):299-308. PubMed ID: 24475340
[TBL] [Abstract][Full Text] [Related]
14. Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China.
Hong K; Gao AH; Xie QY; Gao H; Zhuang L; Lin HP; Yu HP; Li J; Yao XS; Goodfellow M; Ruan JS
Mar Drugs; 2009; 7(1):24-44. PubMed ID: 19370169
[TBL] [Abstract][Full Text] [Related]
15. Potential Bioactive Compounds from Marine Streptomyces sp. and Their In Vitro Antibiofilm and Antibacterial Activities Against Antimicrobial-Resistant Clinical Pathogens.
Dhandapani R; Thangavelu S; Ragunathan L; Paramasivam R; Velmurugan P; Muthupandian S
Appl Biochem Biotechnol; 2022 Oct; 194(10):4702-4723. PubMed ID: 35829903
[TBL] [Abstract][Full Text] [Related]
16. Natural Products from Actinomycetes Associated with Marine Organisms.
Chen J; Xu L; Zhou Y; Han B
Mar Drugs; 2021 Nov; 19(11):. PubMed ID: 34822500
[TBL] [Abstract][Full Text] [Related]
17. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
Li T; Ding T; Li J
Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
[TBL] [Abstract][Full Text] [Related]
18. Marine actinomycetes as an emerging resource for the drug development pipelines.
Zotchev SB
J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
[TBL] [Abstract][Full Text] [Related]
19. Deep Sea Actinomycetes and Their Secondary Metabolites.
Kamjam M; Sivalingam P; Deng Z; Hong K
Front Microbiol; 2017; 8():760. PubMed ID: 28507537
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Characterization of a Novel
Mondal H; Thomas J
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
